ACC 2014. archivos

Day 3

HEAT PPCI: Bivalirudin raises major cardiac events and does not reduce bleeding. The most controversial and criticized study at the ACC 14.

This randomized trial of a single center with consent obtained after randomization compared the use of bivalirudin...

solaci - 24 June, 2015

Day 3

POISE -2: Aspirin before a noncardiac surgery does not reduce the risk of death or myocardial infarction and increased bleeding.

There is great variability in the perioperative administration of aspirin (ASA) in patients undergoing noncardiac surgery, both...

solaci - 24 June, 2015

Day 3

GIPS -III: Metformin does not improve ejection fraction in non-diabetic patients undergoing primary angioplasty

There are experimental studies suggesting that metformin admin before and during ischemia and reperfusion could help to...

solaci - 24 June, 2015

Day 3

STAMPEDE Trial: Bariatric surgery was superior to optimal medical therapy to glycemic control in obese type 2diabetics

In the short term, bariatric surgery showed improvement in glycemic control of obese type 2 diabetics.This study...

solaci - 24 June, 2015

Day 3

SIRS Trial: Methylprednisolone does not decrease mortality and increase the risk of stroke in patients undergoing cardiac surgery

Cardiac surgery with cardiopulmonary bypass results in an inflammatory response of the body that is usually associated...

solaci - 24 June, 2015

Day 3

NEXT Trial: Biodegradable polymer stent (Nobori) was similar to the permanent polymer stents (Xience / Promus) at 2 years.

This multicenter work from Japanrandomized 3200 patients to receive biodegradable polymer biolimus eluting stent(Nobori) or everolimus-eluting stent...

solaci - 24 June, 2015

Day 3

ZEUS Trial: Patients with increased risk of bleeding may benefit from eluting stents Zotarolimus

The use of drug-eluting stents versus bare metal stents is controversial in some clinical situations in patients...

solaci - 24 June, 2015

Day 3

MSC -HF Trial: Auto mesenchymal cell transplantation may improve ventricular function in patients with heart failure of ischemic cause

This study is a phase 2, randomized 2:1, double blind, and placebo-controlled included 59 patients with advanced...

solaci - 24 June, 2015

ACC 2014.

HEAT PPCI: Bivalirudin raises major cardiac events and does not reduce bleeding. The most controversial and criticized study at the ACC 14.

POISE -2: Aspirin before a noncardiac surgery does not reduce the risk of death or myocardial infarction and increased bleeding.

GIPS -III: Metformin does not improve ejection fraction in non-diabetic patients undergoing primary angioplasty

STAMPEDE Trial: Bariatric surgery was superior to optimal medical therapy to glycemic control in obese type 2diabetics

SIRS Trial: Methylprednisolone does not decrease mortality and increase the risk of stroke in patients undergoing cardiac surgery

NEXT Trial: Biodegradable polymer stent (Nobori) was similar to the permanent polymer stents (Xience / Promus) at 2 years.

ZEUS Trial: Patients with increased risk of bleeding may benefit from eluting stents Zotarolimus

MSC -HF Trial: Auto mesenchymal cell transplantation may improve ventricular function in patients with heart failure of ischemic cause

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

The El Salvador 2024 Sessions are coming soon

Check out the best images of the Arequipa 2024 Sessions

Accesos